Biotage
192,7 SEK +1,8%Vær den første som følger denne virksomhed
Biotage is active in biotechnology. The company provides solutions in chromatography, organic synthesis, and sample preparation. The company has operations on a global level, mainly concentrated in Europe, North America, and Asia, and a large part of the projects are also conducted in collaboration with other players in the said market. Customers are found in health and care, as well as in the food industry.
Omsætning
-
EBIT %
-
P/E
57,69
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
BIOT
Daglig lav / høj pris
189,9 / 197,6
SEK
Markedsværdi
15,54 mia. SEK
Aktieomsætning
15,53 mio. SEK
Volumen
80 t
Seneste videoer
Finanskalender
Delårsrapport
23.10.2024
Årsrapport
19.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Gamma Biosciences | 16,9 % | 17,0 % |
SEB Fonder | 7,6 % | 7,7 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Biotage AB (publ) Interim report January-June 2024
![Biotage, Audiocast with teleconference, Q1, 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/89a1822f-8e19-475b-ae2f-f9dd5f79cab9.png)
Biotage, Audiocast with teleconference, Q1, 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Resolutions at the Annual General Meeting in Biotage AB on April 25, 2024
Biotage AB (publ) Interim report January-March 2024
Biotage AB (publ) publishes its 2023 Annual Report and Corporate Governance Report
NOTICE OF ANNUAL GENERAL MEETING OF BIOTAGE AB (PUBL)
![Biotage, Audiocast with teleconference, Q4, 2023](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/1c7a8895-3453-46b4-9fb2-090a10b49299.png)
Biotage, Audiocast with teleconference, Q4, 2023
Biotage AB (publ) publishes new Financial Goals
Biotage appoints Andrew Kellett as CFO
Biotage AB (publ) Year end Report January - December 2023
Biotage CEO & President steps down from his role
![Biotage, Audiocast with teleconference, Q3, 2023](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/b08595ec-662e-4e00-a95f-5a9a6f5dcf41.png)